Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
McEvoy N, Lowry J, O'Dowd A, Curley GF, Fitzpatrick F. McEvoy N, et al. Among authors: fitzpatrick f. Lancet. 2024 Apr 6;403(10434):1337. doi: 10.1016/S0140-6736(23)02880-5. Lancet. 2024. PMID: 38582560 No abstract available.
Rethinking Clostridioides difficile infection (CDI) surveillance definitions based on changing healthcare utilisation and a more realistic incubation period: reviewing data from a tertiary-referral hospital, Ireland, 2012 to 2021.
Skally M, Bennett K, Humphreys H, Fitzpatrick F. Skally M, et al. Among authors: fitzpatrick f. Euro Surveill. 2024 Feb;29(6):2300335. doi: 10.2807/1560-7917.ES.2024.29.6.2300335. Euro Surveill. 2024. PMID: 38333935 Free PMC article.
Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
Khanafer NL, Fitzpatrick F, Barbut F, Krutova M, Davies K, Guery B, Vanhems P. Khanafer NL, et al. Among authors: fitzpatrick f. Eur J Clin Microbiol Infect Dis. 2024 Apr;43(4):785-789. doi: 10.1007/s10096-024-04767-1. Epub 2024 Feb 9. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38332395
European Practice for CDI Treatment.
Fitzpatrick F, Brennan R, van Prehn J, Skally M, Brady M, Burns K, Rooney C, Wilcox MH. Fitzpatrick F, et al. Adv Exp Med Biol. 2024;1435:57-84. doi: 10.1007/978-3-031-42108-2_4. Adv Exp Med Biol. 2024. PMID: 38175471
The Need for European Surveillance of CDI.
Coia CW, Banks AL, Cottom L, Fitzpatrick F. Coia CW, et al. Among authors: fitzpatrick f. Adv Exp Med Biol. 2024;1435:13-31. doi: 10.1007/978-3-031-42108-2_2. Adv Exp Med Biol. 2024. PMID: 38175469
Update on microbiota-derived therapies for recurrent Clostridioides difficile infections.
Benech N, Barbut F, Fitzpatrick F, Krutova M, Davies K, Druart C, Cordaillat-Simmons M, Heritage J, Guery B, Kuijper E; ESGCD and ESGHAMI. Benech N, et al. Among authors: fitzpatrick f. Clin Microbiol Infect. 2024 Apr;30(4):462-468. doi: 10.1016/j.cmi.2023.12.007. Epub 2023 Dec 14. Clin Microbiol Infect. 2024. PMID: 38101472 Review.
Hear my voice: involving patients in Clostridioides difficile infection research.
Strawbridge J, Heritage J, Krůtová M, Guery B, Davies K, Fitzpatrick F, Freeman J. Strawbridge J, et al. Among authors: fitzpatrick f. Clin Microbiol Infect. 2023 Oct;29(10):1222-1224. doi: 10.1016/j.cmi.2023.06.027. Epub 2023 Jun 28. Clin Microbiol Infect. 2023. PMID: 37385469 No abstract available.
365 results